EuroCaps is a capsule contract manufacturer that supplies the nutritional supplement and over-the-counter market with quality softgel products. As a socially responsible company, it strives to maintain a high level of corporate social responsibility and sustainability. We have a commitment to providing high-quality products while staying competitive in the global market.
Pfizer CentreOne
Pfizer CentreOne is a global contract manufacturing organisation embedded within the Pfizer Corporation. Recently, it has expanded its portfolio of services to include contract manufacturing of highly potent solid oral dose medicines. This service is now available at the Pfizer Newbridge, Ireland facility. This facility has a long history of contract manufacturing highly potent solid oral drugs and has regulatory approvals from multiple jurisdictions.
CentreOne’s capabilities span API synthesis, highly potent oral solid dosage forms, and sterile injectables. The company acquired Hospira in 2015 to expand its contract manufacturing business, and it combines this portfolio of capabilities with its own capabilities to serve as a single supplier for highly potent solid dosage forms.
The company also serves as a contract manufacturer for Nexium 24HR, a 20 mg Proton Pump Inhibitor. It is marketed internationally under the brand names Nexium Control and Nexium 24HR.
Robinson Pharma
Robinson Pharma is a Southern California-based contract manufacturer of dietary supplements and nutraceuticals. The company has more than 650,000 square feet of production space and has been in business since 1987. It has multiple third-party certifications, including the Safe Quality Food (SQF) compliance and Eurofins and NPA certifications. The company has a commitment to invest $20 million into its new facility.
Robinson Pharma offers a full-service contract manufacturing solution for the dietary supplements industry. The company offers caplets, sustained-release tablets, chewable tablets, and ready-mix beverage powders. It has more than thirty tablet dies and produces more than 6 billion tablets annually. It also offers custom color imprinting, neck banding, and aqueous clear coating solutions.
Robinson Pharma recently opened a new facility with more than one hundred thousand square feet of production space. The building will be equipped with the latest manufacturing technology, including a Fette 2200i tablet press, Bosche GKF3005 capsule machine, and a GHC 170L1 hi-coater. The facility will also feature modern work spaces for its employees, including custom formulation and machine operations.
Recipharm
Recipharm is a contract development and manufacturing organisation (CDMO). The company is working with RedHill Biopharma on the development of Talicia, a delayed-release capsule that treats Helicobacter pylori infection. The collaboration dates back to 2015 and involves the development of clinical trial materials and methods, as well as the establishment of a commercial manufacturing process.
Recipharm has extended its contract with Daewoong, a Korea-based pharmaceutical company with a strong presence in respiratory therapeutics. The contract runs until 2025. The contract includes manufacturing the finished erdosteine product in Korea. The company will be responsible for providing the finished erdosteine product to Daewoong.